Zepbound is the newest GLP-1 medication to be approved by the Food and Drug Administration (FDA) for weight loss. It’s available only by prescription for people with a body mass index (BMI) of ...

Mounjaro and Zepbound sales disappoint, and Eli Lilly’s stock is dropping Eli Lilly’s stock was set to suffer its worst day in four years after sales of diabetes and obesity drugs Mounjaro and ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Per the partial data released from that phase 3b clinical trial, over 72 weeks of once-weekly treatment with either Zepbound or Wegovy, patients taking Zepbound lost 20.2% of their weight on ...

Crush your enemies and see them driven before you. Conan THE Barbarian joins Mortal Kombat for early access players on January 21. May Crom help us all. Character available with Khaos Reigns ...

A few things about this foreboding, unexpected Flying Wyvern have changed, which you can see for yourself in the exclusive Gravios gameplay videos in this article. As for Gravios, Monster Hunter ...

The EA FC 25 Gameplay Refresh Update will be released soon for PC, PlayStation 4, PlayStation 5, Xbox One, Xbox Series X/S, and the Nintendo Switch. EA Sports has released detailed patch notes ...

EA Sports FC 25 will receive its most significant mid-season update, focusing on core gameplay mechanics. Defensive improvements make it more challenging for defenders to catch up to fast ...

EA Sports FC 25's latest gameplay refresh update has been released Title Update 8 is "the most significant mid-season gameplay overhaul" yet "Major updates" to core gameplay systems have been ...

EA's also deployed an update to FC 25 today that's designed to serve as a "gameplay refresh", with the developer writing that "it’s the most significant mid-season gameplay overhaul we’ve ever ...

Best of luck, and do keep in touch. … When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens ...

Management attributed this lowered guidance to the slowed sales growth of its tirzepatide products in the fourth quarter — diabetes drug Mounjaro added $3.5 billion, while obesity drug Zepbound ...